Cellmid Growth Trifecta, page-15

This lives at the bottom of most newsletters and announcements from CDY

"Forward looking statementsThis publication contains forward-looking statements that are subject to risks and uncertainties. Such statements involve known and unknownrisks that may cause the actual results, performance or achievements of Cellmid to be materially different from the statements in this newsletter.Actual results could differ materially depending on factors such as the availability of resources, the results of clinical studies, the timing andeffects of regulatory actions, the strength of competition and the effectiveness of the Company's patent protection.None of Cellmid Limited, or any of its affiliates or associated companies (or any of their officers, employees, contractors or agents) makes anyrepresentation or warranty as to the accuracy, completeness or reliability of the information in this newsletter, or the likelihood of fulfilment of anyforward looking statement or any outcomes expressed or implied in any forward looking statements."

And from the same newsletter:

Cellmid’s programs underwent an internal and external review process at KDDF, with two programs identified as high-quality candidatesfor partnering. The Korean biotechnology sector is emerging as a sophisticated industry with considerable expertise in biologic drugslinked to the expanding Asian markets,


And in relation to the post on 74 CEO candidates for a company called Advangen Australia.

I do hope the contingent of doomsday merchants and naysayers wandering around making cameo appearances on these threads found sufficient time to tear themselves away from their labours and get an application in for the position.